BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thelen TD, Green RM, Ziegler SF. Acute blockade of IL-25 in a colitis associated colon cancer model leads to increased tumor burden. Sci Rep 2016;6:25643. [PMID: 27165713 DOI: 10.1038/srep25643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Luo X, Villablanca EJ. Type 2 immunity in intestinal homeostasis and inflammatory bowel disease. Biochem Soc Trans 2021;49:2371-80. [PMID: 34581755 DOI: 10.1042/BST20210535] [Reference Citation Analysis]
2 Chang SH. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer. Arch Pharm Res 2019;42:549-59. [DOI: 10.1007/s12272-019-01146-9] [Reference Citation Analysis]
3 Panneerselvam J, Madka V, Rai R, Morris KT, Houchen CW, Chandrakesan P, Rao CV. Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism. Cancers (Basel) 2021;13:5159. [PMID: 34680308 DOI: 10.3390/cancers13205159] [Reference Citation Analysis]
4 Borowczyk J, Shutova M, Brembilla NC, Boehncke WH. IL-25 (IL-17E) in epithelial immunology and pathophysiology. J Allergy Clin Immunol 2021;148:40-52. [PMID: 33485651 DOI: 10.1016/j.jaci.2020.12.628] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
5 Obata-Ninomiya K, de Jesus Carrion S, Hu A, Ziegler SF. Emerging role for thymic stromal lymphopoietin-responsive regulatory T cells in colorectal cancer progression in humans and mice. Sci Transl Med 2022;14:eabl6960. [PMID: 35584230 DOI: 10.1126/scitranslmed.abl6960] [Reference Citation Analysis]
6 Kaewsarabhumi S, Proungvitaya T, Limpaiboon T, Tippayawat P, Tummanatsakun D, Titapun A, Sa-Ngaimwibool P, Proungvitaya S. Interleukin 25 (IL-25) expression in cholangiocarcinoma. Mol Clin Oncol 2020;13:84. [PMID: 33163180 DOI: 10.3892/mco.2020.2154] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Merrouche Y, Fabre J, Cure H, Garbar C, Fuselier C, Bastid J, Antonicelli F, Al-Daccak R, Bensussan A, Giustiniani J. IL-17E synergizes with EGF and confers in vitro resistance to EGFR-targeted therapies in TNBC cells. Oncotarget 2016;7:53350-61. [PMID: 27462789 DOI: 10.18632/oncotarget.10804] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
8 Gowhari Shabgah A, Amir A, Gardanova ZR, Olegovna Zekiy A, Thangavelu L, Ebrahimi Nik M, Ahmadi M, Gholizadeh Navashenaq J. Interleukin-25: New perspective and state-of-the-art in cancer prognosis and treatment approaches. Cancer Med 2021;10:5191-202. [PMID: 34128588 DOI: 10.1002/cam4.4060] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Ge Y, Westphalen CB, Ma WW, Vega KJ, Weygant N. Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers. J Oncol 2019;2019:4835318. [PMID: 32082375 DOI: 10.1155/2019/4835318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Fu Y, Ni J, Chen J, Ma G, Zhao M, Zhu S, Shi T, Zhu J, Huang Z, Zhang J, Chen J. Dual-Functionalized MSCs that Express CX3CR1 and IL-25 Exhibit Enhanced Therapeutic Effects on Inflammatory Bowel Disease. Mol Ther 2020;28:1214-28. [PMID: 32087149 DOI: 10.1016/j.ymthe.2020.01.020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Zheng XL, Wu JP, Gong Y, Hong JB, Xiao HY, Zhong JW, Xie B, Li BM, Guo GH, Zhu X, Wang AJ. IL-25 protects against high-fat diet-induced hepatic steatosis in mice by inducing IL-25 and M2a macrophage production. Immunol Cell Biol 2019;97:165-77. [PMID: 30242904 DOI: 10.1111/imcb.12207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
12 Chang SH. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer. Arch Pharm Res 2019;42:549-59. [DOI: 10.1007/s12272-019-01146-9] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
13 Barati M, Sinaeian M, Shokrollahi Barough M, Pak F, Semnani V, Kokhaei P, Momtazi-Borojeni AA. Evaluation of Interleukin 25 and Interleukin 25 Receptor Expression in Peripheral Blood Mononuclear Cells of Breast Cancer Patients and Normal Subjects. J Interferon Cytokine Res 2020;40:139-44. [PMID: 31905037 DOI: 10.1089/jir.2019.0106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]